Literature DB >> 15719264

[Treatment results after surgery for basal cell carcinomas of the head and neck region taking into consideration various reconstruction techniques].

J-U Piesold1, S Vent, R Krüger, H Pistner.   

Abstract

BACKGROUND: Basal cell carcinomas are the most frequently occurring malignant tumors in the white population. They exhibit a multitude of histological/morphological forms. PATIENTS AND
METHOD: All cases of basal cell carcinoma treated at the department for oral and maxillofacial and regional plastic surgery of the HELIOS hospital in Erfurt between 1976 and 2003 were analyzed and partly reexamined in a retrospective study.
RESULTS: A total of 648 patients with 765 basal cell carcinomas were treated. Occurrences in females dominated those in males with a frequency distribution of 1.24:1. The average age was 70.6 years with a significantly larger number of female seniors above 60. In 64% of the cases the basal cell carcinomas were nodular, in 16% infiltrative. Other morphological/histological forms occurred with a frequency of <or=5%. The most frequent localizations were in of the regions of the highest sun exposure such as the nose, midface, and forehead. DISCUSSION: If an infiltrative basal cell carcinoma is suspected or insufficient radical primary surgery is presumed, plastic reconstruction should be postponed until free margins can be confirmed histologically. The functional and aesthetic quality of reconstruction was better using pedicled flaps (90%) and primary closure (86%) than using free skin transplants (30-54%). Nevertheless, free skin flaps and epitheses were found to be well accepted by the reexamined patients.

Entities:  

Mesh:

Year:  2005        PMID: 15719264     DOI: 10.1007/s10006-005-0594-8

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  10 in total

Review 1.  Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling.

Authors:  G Tim Bowden
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

2.  Guidelines of care for basal cell carcinoma. The American Academy of Dermatology Committee on Guidelines of Care.

Authors:  L A Drake; R I Ceilley; R L Cornelison; W A Dobes; W Dorner; R W Goltz; C W Lewis; S J Salasche; M L Turner; G F Graham
Journal:  J Am Acad Dermatol       Date:  1992-01       Impact factor: 11.527

3.  Micrographic surgery of malignant skin tumors: a comparison of the frozen technique with paraffin sectioning.

Authors:  H Breuninger
Journal:  Facial Plast Surg       Date:  1997-04       Impact factor: 1.446

4.  What causes basal cell carcinoma to be the commonest cancer?

Authors:  J S Gilbody; J Aitken; A Green
Journal:  Aust J Public Health       Date:  1994-06

5.  Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.

Authors:  M Horn; P Wolf; H C Wulf; T Warloe; C Fritsch; L E Rhodes; R Kaufmann; M De Rie; F J Legat; I M Stender; A M Solér; A-M Wennberg; G A E Wong; O Larkö
Journal:  Br J Dermatol       Date:  2003-12       Impact factor: 9.302

6.  A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients.

Authors:  M J Fuente; M Sabat; J Roca; R Lauzurica; M T Fernández-Figueras; C Ferrándiz
Journal:  Br J Dermatol       Date:  2003-12       Impact factor: 9.302

7.  Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).

Authors:  A Katalinic; U Kunze; T Schäfer
Journal:  Br J Dermatol       Date:  2003-12       Impact factor: 9.302

Review 8.  Nevoid basal-cell carcinoma syndrome.

Authors:  R J Gorlin
Journal:  Medicine (Baltimore)       Date:  1987-03       Impact factor: 1.889

9.  Epidemiology and aetiology of basal cell carcinoma.

Authors:  H Tran; K Chen; S Shumack
Journal:  Br J Dermatol       Date:  2003-11       Impact factor: 9.302

10.  Imiquimod in basal cell carcinoma: how does it work?

Authors:  R Dummer; M Urosevic; W Kempf; K Hoek; J Hafner; G Burg
Journal:  Br J Dermatol       Date:  2003-11       Impact factor: 9.302

  10 in total
  1 in total

1.  An anterolateral thigh chimeric flap for dynamic facial and esthetic reconstruction after oncological surgery in the maxillofacial region: a case report.

Authors:  Zoltán Lóderer; Tamás Vereb; Róbert Paczona; Ágnes Janovszky; József Piffkó
Journal:  Head Face Med       Date:  2018-04-11       Impact factor: 2.151

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.